Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|November 4, 2000
Eniluracil: an irreversible inhibitor of dihydropyrimidine dehydrogenaseR L Schilsky, H L KindlerCurrent Treatment Options in Oncology|June 12, 2002
Metastatic colorectal cancerH L Kindler, K L ShulmanClinical Colorectal Cancer|November 26, 2002
Oral fluoropyrimidine treatment of colorectal cancerC Eng, H L Kindler, R L SchilskyAnnals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Phase II study of flavopiridol in patients with advanced colorectal cancerM Aklilu, H L Kindler, R C Donehower, et al.Seminars in Oncology|August 1, 1997
Paclitaxel and carboplatin in early phase studies: Roswell Park Cancer Institute experience in the subset of patients with lung cancerP J Creaven, D Raghavan, L Pendyala, et al.Lung Cancer (Amsterdam, Netherlands)|October 27, 2001
High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study-Cancer and Leukemia Group B 9631M P Kosty, J E Herndon, N J Vogelzang, et al.Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group BH L Kindler, F Millard, J E Herndon, et al.Cancer|November 26, 1999
Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group BH L Kindler, C P Belani, J E Herndon, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2012
Disease volumes as a marker for patient response in malignant pleural mesotheliomaZ E Labby, A K Nowak, J J Dignam, et al.Pageof 2